Mutagenesis and oncogenesis by chromosomal insertion of gene transfer vectors
- PMID: 16544975
- DOI: 10.1089/hum.2006.17.253
Mutagenesis and oncogenesis by chromosomal insertion of gene transfer vectors
Abstract
Increasing evidence reveals that random insertion of gene transfer vectors into the genome of repopulating hematopoietic cells may alter their fate in vivo. Although most insertional mutations are expected to have few if any consequences for cellular survival, clonal dominance caused by retroviral vector insertions in (or in the vicinity of) proto-oncogenes or other signaling genes has been described for both normal and malignant hematopoiesis. Important insights into these side effects were initially obtained in murine models. Results from ongoing clinical studies have revealed that similar adverse events may also occur in human gene therapy. However, it remains unknown to what extent the outcome of insertional mutagenesis induced by gene vectors is related to (1) the architecture and type of vector used, (2) intrinsic properties of the target cell, and (3) extrinsic and potentially disease-specific factors influencing clonal competition in vivo. This review discusses reports addressing these questions, underlining the need for models that demonstrate and quantify the functional consequences of insertional mutagenesis. Improving vector design appears to be the most straightforward approach to increase safety, provided all relevant cofactors are considered.
Similar articles
-
Monitoring for potential adverse effects of prenatal gene therapy: genotoxicity analysis in vitro and on small animal models ex vivo and in vivo.Methods Mol Biol. 2012;891:341-70. doi: 10.1007/978-1-61779-873-3_16. Methods Mol Biol. 2012. PMID: 22648780
-
Insertion of retroviral vectors in NOD/SCID repopulating human peripheral blood progenitor cells occurs preferentially in the vicinity of transcription start regions and in introns.Mol Ther. 2004 Nov;10(5):874-81. doi: 10.1016/j.ymthe.2004.08.001. Mol Ther. 2004. PMID: 15509505
-
Insertional mutagenesis in gene therapy and stem cell biology.Curr Opin Hematol. 2007 Jul;14(4):337-42. doi: 10.1097/MOH.0b013e3281900f01. Curr Opin Hematol. 2007. PMID: 17534158 Review.
-
Cell-intrinsic and vector-related properties cooperate to determine the incidence and consequences of insertional mutagenesis.Mol Ther. 2009 Sep;17(9):1537-47. doi: 10.1038/mt.2009.134. Epub 2009 Jun 16. Mol Ther. 2009. PMID: 19532134 Free PMC article.
-
Mechanisms of retroviral integration and mutagenesis.Hum Gene Ther. 2013 Feb;24(2):119-31. doi: 10.1089/hum.2012.203. Hum Gene Ther. 2013. PMID: 23330935 Review.
Cited by
-
A combinatorial library of biodegradable polyesters enables non-viral gene delivery to post-mitotic human stem cell-derived polarized RPE monolayers.Regen Eng Transl Med. 2019 Sep;6(3):273-285. doi: 10.1007/s40883-019-00118-1. Epub 2019 Jul 24. Regen Eng Transl Med. 2019. PMID: 33732871 Free PMC article.
-
Continuous Production of Discrete Plasmid DNA-Polycation Nanoparticles Using Flash Nanocomplexation.Small. 2016 Dec;12(45):6214-6222. doi: 10.1002/smll.201601425. Epub 2016 Sep 22. Small. 2016. PMID: 27717227 Free PMC article.
-
Advances in human pluripotent stem cell reporter systems.iScience. 2024 Aug 30;27(9):110856. doi: 10.1016/j.isci.2024.110856. eCollection 2024 Sep 20. iScience. 2024. PMID: 39290832 Free PMC article. Review.
-
siRNA nanoparticle functionalization of nanostructured scaffolds enables controlled multilineage differentiation of stem cells.Mol Ther. 2010 Nov;18(11):2018-27. doi: 10.1038/mt.2010.166. Epub 2010 Aug 31. Mol Ther. 2010. PMID: 20808289 Free PMC article.
-
mRNA transfection by a Xentry-protamine cell-penetrating peptide is enhanced by TLR antagonist E6446.PLoS One. 2018 Jul 30;13(7):e0201464. doi: 10.1371/journal.pone.0201464. eCollection 2018. PLoS One. 2018. PMID: 30059522 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources